On Invalid Date, Alvotech (NASDAQ: ALVO) reported Q3 2023 earnings per share (EPS) of -$0.82, up 4,200% year over year. Total Alvotech earnings for the quarter were -$188.32 million. In the same quarter last year, Alvotech's earnings per share (EPS) was $0.02.
As of Q4 2023, Alvotech's earnings has grown year over year. Alvotech's earnings in the past year totalled -$595.68 million.
What was ALVO's revenue last quarter?
On Invalid Date, Alvotech (NASDAQ: ALVO) reported Q3 2023 revenue of $17.80 million up 6.85% year over year. In the same quarter last year, Alvotech's revenue was $19.11 million.
What was ALVO's revenue growth in the past year?
As of Q4 2023, Alvotech's revenue has grown -33.69% year over year. This is 44.87 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 11.19%. Alvotech's revenue in the past year totalled $63.75 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.